Blocking the lactate/GPR81 pathway with metformin can effectively inhibit glycolysis and decrease lactate levels within tumours, thereby increasing the number of CD8+ T cells in tumour tissue and IFN-γ secretion in lymph nodes. This evidence concerns the gene HCAR1 and neoplasm.